134 related articles for article (PubMed ID: 19494710)
1. The (-174) G/C polymorphism in the interleukin-6 gene is associated with risk of papillary thyroid carcinoma in Turkish patients.
Ozgen AG; Karadeniz M; Erdogan M; Berdeli A; Saygili F; Yilmaz C
J Endocrinol Invest; 2009 Jun; 32(6):491-4. PubMed ID: 19494710
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-10 gene polymorphism in patients with papillary thyroid cancer in Turkish population.
Erdogan M; Karadeniz M; Ozbek M; Ozgen AG; Berdeli A
J Endocrinol Invest; 2008 Sep; 31(9):750-4. PubMed ID: 18997484
[TBL] [Abstract][Full Text] [Related]
3. Association between IL-27 gene polymorphisms and risk of papillary thyroid carcinoma.
Nie X; Yuan F; Chen P; Pu Y; Zhu J; Wang Y; Xiao X; Che G; Gao L; Zhang L
Biomark Med; 2017 Feb; 11(2):141-149. PubMed ID: 27929666
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-10-1082 gene polymorphism is associated with papillary thyroid cancer.
Çil E; Kumral A; Kanmaz-Özer M; Vural P; Doğru-Abbasoğlu S; Altuntaş Y; Uysal M
Mol Biol Rep; 2014 May; 41(5):3091-7. PubMed ID: 24464184
[TBL] [Abstract][Full Text] [Related]
5. Fas/Fas ligand gene polymorphism in patients with papillary thyroid cancer in the Turkish population.
Erdogan M; Karadeniz M; Berdeli A; Tamsel S; Ertan Y; Uluer H; Yilmaz C; Tuzun M; Kabalak T; Ozgen AG
J Endocrinol Invest; 2007 May; 30(5):411-6. PubMed ID: 17598974
[TBL] [Abstract][Full Text] [Related]
6. MMP-9-1562 C/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progression.
Roncevic J; Djoric I; Selemetjev S; Jankovic J; Dencic TI; Bozic V; Cvejic D
Pathology; 2019 Jan; 51(1):55-61. PubMed ID: 30497805
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 27 -964A > G genetic polymorphism and serum IL-27p28 levels in Chinese patients with papillary thyroid cancer.
Zhang S; Gao X; Wang Y; Jia J; Zhang Q; Ji Z
Tumour Biol; 2015 Sep; 36(10):8207-11. PubMed ID: 25994572
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma.
Bingül İ; Vural P; Doğru-Abbasoğlu S; Çil E; Uysal M
J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 27925342
[TBL] [Abstract][Full Text] [Related]
9. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.
Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D
Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935
[TBL] [Abstract][Full Text] [Related]
10. 1513A>C polymorphism in the P2X7 receptor gene in patients with papillary thyroid cancer: correlation with histological variants and clinical parameters.
Dardano A; Falzoni S; Caraccio N; Polini A; Tognini S; Solini A; Berti P; Di Virgilio F; Monzani F
J Clin Endocrinol Metab; 2009 Feb; 94(2):695-8. PubMed ID: 19017759
[TBL] [Abstract][Full Text] [Related]
11. The effect of TP53 and P21 gene polymorphisms on papillary thyroid carcinoma susceptibility and clinical/pathological features.
Heidari Z; Harati-Sadegh M; Arian A; Maruei-Milan R; Salimi S
IUBMB Life; 2020 May; 72(5):922-930. PubMed ID: 31895498
[TBL] [Abstract][Full Text] [Related]
12. Role of PTPRJ genotype in papillary thyroid carcinoma risk.
Iuliano R; Palmieri D; He H; Iervolino A; Borbone E; Pallante P; Cianflone A; Nagy R; Alder H; Calin GA; Trapasso F; Giordano C; Croce CM; de la Chapelle A; Fusco A
Endocr Relat Cancer; 2010 Dec; 17(4):1001-6. PubMed ID: 20823296
[TBL] [Abstract][Full Text] [Related]
13. Associations between promoter polymorphism -106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population.
Eun YG; Shin IH; Kim MJ; Chung JH; Song JY; Kwon KH
Surgery; 2012 Feb; 151(2):323-9. PubMed ID: 21982075
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of the Highly Expressed IL-6 Gene in the Papillary Thyroid Cancer Susceptibility Among Chinese.
Li H; Dai H; Li H; Li B; Shao Y
Curr Mol Med; 2019; 19(6):443-451. PubMed ID: 31288714
[TBL] [Abstract][Full Text] [Related]
15. Association of
Chatzikyriakidou A; Chorti A; Papavramidis T
In Vivo; 2019; 33(6):2281-2285. PubMed ID: 31662568
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma.
Halkova T; Dvorakova S; Sykorova V; Vaclavikova E; Vcelak J; Vlcek P; Sykorova P; Kodetova D; Betka J; Lastuvka P; Bavor P; Hoch J; Katra R; Bendlova B
Cancer Biomark; 2016 Jun; 17(1):97-106. PubMed ID: 27314298
[TBL] [Abstract][Full Text] [Related]
17. Role of MDM2 309T>G (rs2279744) and I/D (rs3730485) polymorphisms and haplotypes in risk of papillary thyroid carcinoma, tumor stage, tumor size, and early onset of tumor: A case control study.
Maruei-Milan R; Heidari Z; Salimi S
J Cell Physiol; 2019 Aug; 234(8):12934-12940. PubMed ID: 30548972
[TBL] [Abstract][Full Text] [Related]
18. VDR gene FokI polymorphism as a poor prognostic factor for papillary thyroid cancer.
Beysel S; Eyerci N; Pinarli FA; Apaydin M; Kizilgul M; Caliskan M; Ozcelik O; Kan S; Cakal E
Tumour Biol; 2018 Nov; 40(11):1010428318811766. PubMed ID: 30486759
[TBL] [Abstract][Full Text] [Related]
19. Role of Caspase 8, Caspase 9 and Bcl-2 polymorphisms in papillary thyroid carcinoma risk in Han Chinese population.
Wang YX; Zhao L; Wang XY; Liu CM; Yu SG
Med Oncol; 2012 Dec; 29(4):2445-51. PubMed ID: 22120515
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms at the IL17A and IL17RA Genes are Associated with Prognosis of Papillary Thyroid Carcinoma.
Bertol BC; Góes de Araújo JN; de Carvalho KTC; Gonzaga Dos Santos M; Martelli-Palomino G; de Figueiredo Feitosa NL; Maciel LMZ; Silbiger VN; Lucena-Silva N; Freitas JCOC; Donadi EA
Arch Med Res; 2022 Feb; 53(2):163-169. PubMed ID: 34384609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
